Israel Welcomes Russian COVID-19 Vaccine Recipients

The Russian Direct Investment Fund (RDIF) announced on October 28, 2021, that Israeli authorities had approved the entry of individuals vaccinated with the Sputnik V vaccine.

To date, a total of 101 countries have approved the entry of people vaccinated with the Sputnik V vaccine.

The Sputnik V vaccine is not recognized by the World Health Organization or the U.S. Food and Drug Administration.

Separating authorization of COVID vaccines from vaccination certificates is another essential step to avoiding vaccine discrimination and supporting governments' efforts in safely re-opening borders for both locals and tourists, stated the RDIF.

Sputnik V is an adenoviral-based, two-dose vaccine against the SARS-CoV-2 coronavirus. Initially produced in Russia in August 2020, and now in 20 countries, Sputnik V uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.

Adenovirus is used as a "container" to deliver the coronavirus gene to cells and start synthesizing the virus's envelope proteins, "introducing" the immune system to a potential enemy. The cells then use the gene to produce the spike protein. The person's immune system treats this spike protein as foreign and produces natural defenses, antibodies, and T cells, against this protein.

The Sputnik Light vaccine is a one-dose version.